Warning letter
RICARIMPEX SAS CO.: warning letter of May 14, 2015
FDA warning letter UCM477821 · Center for Devices and Radiological Health
Key facts
| Reference number | UCM477821 |
|---|---|
| Company | RICARIMPEX SAS CO. |
| Subject | CGMP/QSR/Medical Devices/Adulterated |
| Issue date | May 14, 2015 |
| Posted date | May 14, 2015 |
| Issuing office | Center for Devices and Radiological Health |
| Product type | Devices |
| CFR sections cited | 803, 803.3, 803.50(a)(1), 820, 803.50(a) |
| Country | 3 |
| Inspection city | Eysines |
| Inspection start date | Jan 12, 2015 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: